Abbott Laboratories ABTT34.SA Stock
Abbott Laboratories Price Chart
Abbott Laboratories ABTT34.SA Financial and Trading Overview
Abbott Laboratories stock price | 47 BRL |
Previous Close | 41.6 BRL |
Open | 0 BRL |
Bid | 41.76 BRL x 0 |
Ask | 42.56 BRL x 0 |
Day's Range | 0 - 0 BRL |
52 Week Range | 0 - 51 BRL |
Volume | 0 BRL |
Avg. Volume | 125 BRL |
Market Cap | 886.59B BRL |
Beta (5Y Monthly) | 0.663028 |
PE Ratio (TTM) | 31.864662 |
EPS (TTM) | 1.38 BRL |
Forward Dividend & Yield | 0.83 (2.02%) |
Ex-Dividend Date | April 13, 2023 |
1y Target Est | N/A |
ABTT34.SA Valuation Measures
Enterprise Value | 294.43B BRL |
Trailing P/E | 31.864662 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 21.36103 |
Price/Book (mrq) | 7.9650426 |
Enterprise Value/Revenue | 7.094 |
Enterprise Value/EBITDA | 27.463 |
Trading Information
Abbott Laboratories Stock Price History
Beta (5Y Monthly) | 0.663028 |
52-Week Change | -5.88% |
S&P500 52-Week Change | 20.43% |
52 Week High | 51 BRL |
52 Week Low | 0 BRL |
50-Day Moving Average | 44.12 BRL |
200-Day Moving Average | 45.12 BRL |
ABTT34.SA Share Statistics
Avg. Volume (3 month) | 125 BRL |
Avg. Daily Volume (10-Days) | 260 BRL |
Shares Outstanding | 20.87B |
Float | 6.9B |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.96 |
Trailing Annual Dividend Yield | 4.71% |
5 Year Average Dividend Yield | 131.00% |
Payout Ratio | 0.4458 |
Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 13.98% |
Operating Margin (ttm) | 18.00% |
Gross Margin | 55.63% |
EBITDA Margin | 25.83% |
Management Effectiveness
Return on Assets (ttm) | 6.31% |
Return on Equity (ttm) | 15.93% |
Income Statement
Revenue (ttm) | 41.51B BRL |
Revenue Per Share (ttm) | 5.94 BRL |
Quarterly Revenue Growth (yoy) | -18.099% |
Gross Profit (ttm) | 24.58B BRL |
EBITDA | 10.72B BRL |
Net Income Avi to Common (ttm) | 5.78B BRL |
Diluted EPS (ttm) | 1.33 |
Quarterly Earnings Growth (yoy) | -46.10% |
Balance Sheet
Total Cash (mrq) | 9.53B BRL |
Total Cash Per Share (mrq) | 1.37 BRL |
Total Debt (mrq) | 17.03B BRL |
Total Debt/Equity (mrq) | 45.73 BRL |
Current Ratio (mrq) | 1.678 |
Book Value Per Share (mrq) | 5.32075 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.66B BRL |
Levered Free Cash Flow (ttm) | 6.41B BRL |
Profile of Abbott Laboratories
Country | Brazil |
State | IL |
City | North Chicago |
Address | 100 Abbott Park Road |
ZIP | 60064-6400 |
Phone | 224 667 6100 |
Website | https://www.abbott.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 115000 |
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Q&A For Abbott Laboratories Stock
What is a current ABTT34.SA stock price?
Abbott Laboratories ABTT34.SA stock price today per share is 47 BRL.
How to purchase Abbott Laboratories stock?
You can buy ABTT34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Abbott Laboratories?
The stock symbol or ticker of Abbott Laboratories is ABTT34.SA.
Which industry does the Abbott Laboratories company belong to?
The Abbott Laboratories industry is Medical Devices.
How many shares does Abbott Laboratories have in circulation?
The max supply of Abbott Laboratories shares is 20.82B.
What is Abbott Laboratories Price to Earnings Ratio (PE Ratio)?
Abbott Laboratories PE Ratio is 34.05797200 now.
What was Abbott Laboratories earnings per share over the trailing 12 months (TTM)?
Abbott Laboratories EPS is 1.38 BRL over the trailing 12 months.
Which sector does the Abbott Laboratories company belong to?
The Abbott Laboratories sector is Healthcare.